Zipalertinib (TAS6417, CLN-081) is a highly effective, orally active and pan-mutation-selective EGFR tyrosine kinase inhibitor with a unique scaffold fitting into the ATP-binding site of the EGFR hinge region, with IC50 values ranging from 1.1-8.0 nM[1][2].
Molecular Weight:
396.44
Purity:
99.62
CAS Number:
[1661854-97-2]
Formula:
C23H20N6O
Target:
Apoptosis,EGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
